|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3290421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17191163.9 |
| Date of filing the European patent application | 2014-02-11 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation | 2019-02-25 |
| (30) | Number | Date | Country code |
| 201361767947 P | 2013-02-22 | US |
| (72) |
BROWN, Matthew Frank, US
FENWICK, Ashley Edward, US
FLANAGAN, Mark Edward, US
GONZALES, Andrea, US
JOHNSON, Timothy Allan, US
KAILA, Neelu, US
MITTON-FRY, Mark J., US
STROHBACH, Joseph Walter, US
TENBRINK, Ruth E., US
TRZUPEK, John David, US
UNWALLA, Rayomand Jal, US
VAZQUEZ, Michael L., US
PARIKH, Mihir, D., US
|
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolo [2, 3 -d]pirimidino darinių derinys su vienu arba daugiau papildomų agentų, kaip Janus kinazės (JAK) inhibitorių |
| COMBINATION OF PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES WITH ONE OR MORE ADDITIONAL AGENTS AS INHIBITORS OF JANUS- RELATED KINASES (JAK) |
| Payment date | Validity (years) | Amount | |
| 2025-01-17 | 12 | 289.00 EUR |
| 2026-02-11 |